Introduction Skin rash is the most common adverse effect in patients with cancer receiving epidermal growth factor receptor inhibitors (EGFRIs), which can impair quality of life and lead to treatment ...
Morning Overview on MSN
Study links anti-tumor immunity to autoimmune risks like anti-NMDA encephalitis
Immune checkpoint inhibitors have reshaped cancer treatment over the past decade, but the same immune activation that shrinks tumors can also turn against healthy tissue, including the brain. A ...
Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...
NEW YORK, March 24, 2026 /PRNewswire/ -- Previvor Edge, a preventive cancer care organization, today announced an expansion of its clinical platform that dramatically accelerates the delivery of ...
BOSTON & ALLENTOWN, Pa.--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading ...
People with inflammatory bowel disease (IBD) and precancerous colorectal lesions are much more likely to develop colorectal cancer, a new study shows. Led by researchers from NYU Langone Health, the ...
Harvard University has been trying to cut back how many A grades professors give. Now, 53 percent of grades are A’s, down from 60 percent. By Mark Arsenault It used to be unusual for a Harvard student ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
A new scale for grading ocular adverse events in oncology trials addresses ambiguities in CTCAE version 5 and includes dose modification recommendations. The scale, implemented in the I-SPY 2 trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results